# Taisho Pharmaceutical (M) SDN BHD – FDA Inspection, Nov 2, 2023

Source: https://www.keypedia.com/records/fda_inspections/taisho-pharmaceutical-m-sdn-bhd/b3db14dd-831c-477d-9b8c-4a5472850d0b
Source feed: FDA_Inspections

> FDA inspection 1222097 of Taisho Pharmaceutical (M) SDN BHD, November 02, 2023. Classification: Voluntary Action Indicated (VAI). 10 citations under 21 CFR parts 108 and 111. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1222097
- Company Name: Taisho Pharmaceutical (M) SDN BHD
- Inspection Date: 2023-11-02
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Foodborne Biological Hazards
- Product Type: Food/Cosmetics
- Center: Foods & Cosmetics
- Office Name: Center for Food Safety and Applied Nutrition
- Citation Count: 10

## Related Officers

- [Company Rep](https://www.keypedia.com/people/phal-k-chhun/5b9e07c1-c9cd-457d-b6e3-275bcdca157d)

Company: https://www.keypedia.com/companies/taisho-pharmaceutical-m-sdn-bhd/880a9c7d-2d79-4c34-91a8-6235394c5704

Office: https://www.keypedia.com/offices/center-for-food-safety-and-applied-nutrition/e04dc4e5-ee4f-4b0d-be8c-1139531ddab2